The need for performing clinical trials to develop well-studied and appropriate medicines for inherited neurometabolic disease patients faces ethical concerns mainly raising from four aspects: the diseases are rare; include young and very young patients; the neurological impairment may compromise the capability to provide ‘consent’; and the genetic nature of the disease leads to further ethical implications. This work is intended to identify the ethical provisions applicable to clinical research involving these patients and to evaluate if these cover the ethical issues. Three searches have been performed on the European regulatory/legal framework, the literature and European Union-funded projects. The European legal framework offers a numbe...
Genetic research involving humans as well as the commercialisation of its results both raise intrica...
The practice of genetic counselling gives rise to many ethical dilemmas, and counsellors need to be ...
textabstractFor a significant number of patients, there exists no, or only little, interest in devel...
The need for performing clinical trials to develop well-studied and appropriate medicines for inheri...
Drug trials in children engage with many ethical issues, from drug-related safety concerns to commun...
Drug trials in children engage with many ethical issues, from drug-related safety concerns to commun...
Background: Genomic research on neurodevelopmental disorders (NDDs), particularly involving minors, ...
Health care providers and families with children who participate in genetic research or who need spe...
International audienceBACKGROUND: The EU LeukoTreat program aims to connect, enlarge and improve exi...
BACKGROUND: Prader-Willi Syndrome (PWS) is a rare genetically determined neurodevelopmental disorder...
Knowledge of genetic mechanisms contributing to neurodevelopmental conditions is advancing. This is ...
Genetic testing is now an integral part of most areas of medicine, but especially neurological servi...
Rare diseases are human pathologies which are not frequent in the human population (1/2000). For thi...
Huntington’s is a genetic neurodegenerative disease with dominant autosomal transmission, and high p...
In this chapter we briefly outline key philosophy and bioethics dimensions of a genomics medicine ca...
Genetic research involving humans as well as the commercialisation of its results both raise intrica...
The practice of genetic counselling gives rise to many ethical dilemmas, and counsellors need to be ...
textabstractFor a significant number of patients, there exists no, or only little, interest in devel...
The need for performing clinical trials to develop well-studied and appropriate medicines for inheri...
Drug trials in children engage with many ethical issues, from drug-related safety concerns to commun...
Drug trials in children engage with many ethical issues, from drug-related safety concerns to commun...
Background: Genomic research on neurodevelopmental disorders (NDDs), particularly involving minors, ...
Health care providers and families with children who participate in genetic research or who need spe...
International audienceBACKGROUND: The EU LeukoTreat program aims to connect, enlarge and improve exi...
BACKGROUND: Prader-Willi Syndrome (PWS) is a rare genetically determined neurodevelopmental disorder...
Knowledge of genetic mechanisms contributing to neurodevelopmental conditions is advancing. This is ...
Genetic testing is now an integral part of most areas of medicine, but especially neurological servi...
Rare diseases are human pathologies which are not frequent in the human population (1/2000). For thi...
Huntington’s is a genetic neurodegenerative disease with dominant autosomal transmission, and high p...
In this chapter we briefly outline key philosophy and bioethics dimensions of a genomics medicine ca...
Genetic research involving humans as well as the commercialisation of its results both raise intrica...
The practice of genetic counselling gives rise to many ethical dilemmas, and counsellors need to be ...
textabstractFor a significant number of patients, there exists no, or only little, interest in devel...